TM-Logo-Navy.png
Novotech Signs Strategic MOU with Hong Kong-Shenzhen Innovation and Technology Park Limited (HSITPL)
May 29, 2024 22:43 ET | Novotech
Novotech today announced it has signed a Memorandum of Understanding (MOU) with Hong Kong-Shenzhen Innovation and Technology Park Limited (HSITPL).
TM-Logo-Navy.png
Novotech Announces MOU with Experienced Psychedelics Research Center at the 4th Annual Psychedelic Therapeutics and Drug Development Conference in Boston
May 22, 2024 20:11 ET | Novotech
Novotech Announces MOU with Experienced Psychedelics Research Center at the 4th Annual Psychedelic Therapeutics and Drug Development Conference in Boston
TM-Logo-Navy.png
Novotech Appoints Commercial and Clinical Life Sciences Specialist to Head Up Global Drug Development Consulting Team
May 02, 2024 17:00 ET | Novotech
Novotech CRO appoints Scott Schliebner as Vice President and Global Head, Drug Development Consulting (DDC).
Acute Myeloid Leukemia (AML)
Novotech Publishes Research Report on Acute Myeloid Leukaemia Clinical Trial Landscape for Clinical Stage Biotechs
April 10, 2024 22:37 ET | Novotech
The report presents a comprehensive look at the AML funding landscape, trial density, patient recruitment data
Cystic Fibrosis (CF)
Novotech Publishes Analyst Report on Cystic Fibrosis Clinical Trial Landscape to Inform Biotech Research Planning 
April 10, 2024 22:33 ET | Novotech
The report presents a data-backed review of the Cystic Fibrosis (CF) funding landscape, trial density, and patient recruitment data.
PRECISION ONCOLOGY GLOBAL CLINICAL TRIAL LANDSCAPE (2024)
Novotech Publishes Precision Oncology Landscape Whitepaper Identifying Current Trends and Opportunities in Targeted Therapies
March 12, 2024 20:01 ET | Novotech
Novotech CRO has released an insightful whitepaper, Precision Oncology - Global Clinical Trial Landscape, providing the latest research insights for cancer
Duchenne Muscular Dystrophy (DMD) Clinical Trial Landscape
Novotech Publishes Duchenne Muscular Dystrophy Landscape Report to Support Biotech Research Planning
February 28, 2024 01:32 ET | Novotech
Novotech has released today an industry-leading report on Duchenne Muscular Dystrophy (DMD) Clinical Trial Landscape.
RHEUMATOID ARTHRITIS
Novotech Publishes Candidiasis and Rheumatoid Arthritis Clinical Trial Landscape Reports to Support Biotech Research Planning
February 11, 2024 21:26 ET | Novotech
Novotech CRO has released today two industry-leading reports on the Candidiasis and Rheumatoid Arthritis clinical trial landscapes.
TM-logo-no-tag-navy-brand-rec-white 1.jpg
Novotech Executive Team at J.P. Morgan Healthcare Conference: Global CRO Designed for Biotechs Across 25 Regions
January 08, 2024 07:38 ET | Novotech
Novotech announced today that it will have the largest ever presence at the J.P.Morgan Healthcare Conference in San Francisco, CA, USA, January 8-11, 2024.
MBC
New Novotech Report on Metastatic Breast Cancer Identifies 1,000 Clinical Trials Globally Since 2018
December 30, 2023 04:18 ET | Novotech
Novotech today released the latest 2023 global clinical trial landscape reports on Metastatic Breast Cancer.